about
Non-viral therapeutic approaches to ocular diseases: An overview and future directionsNanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.A new developing class of gene delivery: messenger RNA-based therapeutics.Gene therapy with nonviral poly(ε-caprolactone) nanoparticles.Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles
P2860
Q36425890-619DCD51-1504-4659-AC24-750245BF6A15Q39091854-CD9A3283-50BE-44D7-A082-44FBAF2197BCQ45873514-4E6D01E0-C5D3-491E-9CE3-5354E328E3F7Q45878200-1D3E1B3A-C41F-4155-A5F2-496356B4DAEBQ47233994-96BE0303-6617-40DD-9637-565EDDA69E90Q52579601-6005954E-3E58-4478-8DD8-59E2B697B3A8Q57154802-AC7A1089-3634-4292-89DE-B1E1B0BB3178
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
mRNA delivery using non-viral PCL nanoparticles.
@en
type
label
mRNA delivery using non-viral PCL nanoparticles.
@en
prefLabel
mRNA delivery using non-viral PCL nanoparticles.
@en
P2860
P356
P1433
P1476
mRNA delivery using non-viral PCL nanoparticles
@en
P2093
Giuseppe Gigli
Stefania D'Amone
P2860
P304
P356
10.1039/C4BM00242C
P577
2014-09-17T00:00:00Z